chr1-182586804-C-T
Position:
Variant summary
Our verdict is Likely pathogenic. Variant got 8 ACMG points: 9P and 1B. PVS1PP5BS2_Supporting
The ENST00000367559.7(RNASEL):c.3G>A(p.Met1?) variant causes a start lost change. The variant allele was found at a frequency of 0.0000235 in 1,614,026 control chromosomes in the GnomAD database, with no homozygous occurrence. Variant has been reported in ClinVar as Pathogenic (no stars).
Frequency
Genomes: 𝑓 0.00018 ( 0 hom., cov: 32)
Exomes 𝑓: 0.0000068 ( 0 hom. )
Consequence
RNASEL
ENST00000367559.7 start_lost
ENST00000367559.7 start_lost
Scores
2
7
7
Clinical Significance
Conservation
PhyloP100: 4.01
Genes affected
RNASEL (HGNC:10050): (ribonuclease L) This gene encodes a component of the interferon-regulated 2-5A system that functions in the antiviral and antiproliferative roles of interferons. The protein is involved in innate immunity and is active against multiple RNA viruses, including the influenza and SARS-CoV-2 viruses. Mutations in this gene have been associated with predisposition to prostate cancer and this gene is a candidate for the hereditary prostate cancer 1 (HPC1) allele. [provided by RefSeq, Nov 2021]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Likely_pathogenic. Variant got 8 ACMG points.
PVS1
Start lost variant, no new inframe start found.
PP5
Variant 1-182586804-C-T is Pathogenic according to our data. Variant chr1-182586804-C-T is described in ClinVar as [Pathogenic]. Clinvar id is 13005.Status of the report is no_assertion_criteria_provided, 0 stars.
BS2
High AC in GnomAd4 at 28 AD gene. Variant has AC lower than other variant known as pathogenic in the gene, so the strength is limited to Supporting.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
RNASEL | NM_021133.4 | c.3G>A | p.Met1? | start_lost | 2/7 | ENST00000367559.7 | NP_066956.1 | |
RNASEL | XM_047427096.1 | c.3G>A | p.Met1? | start_lost | 2/7 | XP_047283052.1 | ||
RNASEL | XM_047427106.1 | c.3G>A | p.Met1? | start_lost | 2/6 | XP_047283062.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
RNASEL | ENST00000367559.7 | c.3G>A | p.Met1? | start_lost | 2/7 | 1 | NM_021133.4 | ENSP00000356530 | P1 | |
RNASEL | ENST00000539397.1 | c.3G>A | p.Met1? | start_lost | 2/6 | 2 | ENSP00000440844 |
Frequencies
GnomAD3 genomes AF: 0.000184 AC: 28AN: 152240Hom.: 0 Cov.: 32
GnomAD3 genomes
AF:
AC:
28
AN:
152240
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.0000200 AC: 5AN: 249632Hom.: 0 AF XY: 0.00 AC XY: 0AN XY: 135244
GnomAD3 exomes
AF:
AC:
5
AN:
249632
Hom.:
AF XY:
AC XY:
0
AN XY:
135244
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.00000684 AC: 10AN: 1461786Hom.: 0 Cov.: 35 AF XY: 0.00000550 AC XY: 4AN XY: 727192
GnomAD4 exome
AF:
AC:
10
AN:
1461786
Hom.:
Cov.:
35
AF XY:
AC XY:
4
AN XY:
727192
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.000184 AC: 28AN: 152240Hom.: 0 Cov.: 32 AF XY: 0.000148 AC XY: 11AN XY: 74368
GnomAD4 genome
AF:
AC:
28
AN:
152240
Hom.:
Cov.:
32
AF XY:
AC XY:
11
AN XY:
74368
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
ESP6500AA
AF:
AC:
4
ESP6500EA
AF:
AC:
0
ExAC
AF:
AC:
6
ClinVar
Significance: Pathogenic
Submissions summary: Pathogenic:1
Revision: no assertion criteria provided
LINK: link
Submissions by phenotype
Prostate cancer, hereditary, 1 Pathogenic:1
Pathogenic, no assertion criteria provided | literature only | OMIM | Feb 01, 2002 | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_addAF
Pathogenic
D
BayesDel_noAF
Uncertain
CADD
Benign
DANN
Uncertain
DEOGEN2
Benign
T;.
Eigen
Benign
Eigen_PC
Benign
FATHMM_MKL
Uncertain
D
LIST_S2
Uncertain
D;D
M_CAP
Pathogenic
D
MetaRNN
Uncertain
D;D
MetaSVM
Benign
T
MutationTaster
Benign
A;A;A
PROVEAN
Benign
N;N
REVEL
Benign
Sift
Uncertain
D;D
Sift4G
Uncertain
D;D
Polyphen
B;.
Vest4
MutPred
Gain of stability (P = 0.0523);Gain of stability (P = 0.0523);
MVP
ClinPred
T
GERP RS
Varity_R
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at